Navigation Links
GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial
Date:10/30/2007

Overall Survival Results Do Not Achieve Statistical Significance

IRVINE, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc.'s (Nasdaq: SPPI) licensee, GPC Biotech, today announced that the Phase 3 SPARC trial evaluating satraplatin for the treatment of hormone-refractory prostate cancer did not meet its primary efficacy endpoint.

"We are indeed disappointed that the overall survival data for satraplatin did not achieve statistical significance. Drug development is inherently risky and clinical studies do sometimes fail for various reasons, which is why we built Spectrum on a business model based on a diversified portfolio of several late- and early-stage drug candidates. We are not dependent on the success or failure of any one drug," said Rajesh C. Shrotriya, M.D., Chairman, President and Chief Executive Officer of Spectrum Pharmaceuticals, Inc. "We will continue to aggressively develop our four late-stage drugs, ISO-Vorin(TM), which has a January 11th FDA action date; sumatriptan injection, which we will launch with PAR Pharmaceutical Companies in the second-half of 2008; EOquin(R), which is currently enrolling patients in two Phase 3 trials; and ozarelix, where we are currently working on the protocol for the pivotal registrational trial. Furthermore, we are currently planning and/or conducting studies for elsamitrucin, lucanthone, ortataxel, RenaZorb(TM), SPI-1620 and SPI-205."

About Satraplatin

In 2002, Spectrum licensed the global rights to GPC Biotech (Frankfurt Stock Exchange: GPC; TecDAX index; Nasdaq: GPCB). GPC Biotech is responsible for all costs associated with the development and regulatory filings of Satraplatin. GPC Biotech has license agreements with Ph
'/>"/>

SOURCE Spectrum Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Finland and India to interact and cooperate in the filed of telemedicine and biotechnology
9. Vical Biotech and NIH jointly develops HIV vaccine
10. Biotechnology Initiatives Planned In Hyderabad
11. Biotech Osiris to go public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... With the accelerated aging of the ... as well as the improved medical care facilities ... industry has been developing quickly, especially in vitro ... in vitro diagnostics market size reached RMB22.98 billion, ... diagnostic reagents. , Chinese in vitro diagnostic ...
(Date:7/30/2014)... Angeles, California (PRWEB) July 30, 2014 ... an online dating community where motorcycle enthusiasts congregate, ... on the site that were revealed by BikerKiss indicate ... increase in the past 3 years. , Members on ... US, UK, Canada, Australia and some other European countries ...
(Date:7/30/2014)... WA (PRWEB) July 30, 2014 According to ... Vkool.com, this is a comprehensive bodybuilding guide for men who ... by up to 50 pounds in within a few ... that will help keep their shoulders healthy and avoid the ... the Critical Bench Program 2.0 uncovers to learners the reason ...
(Date:7/30/2014)... San Diego, CA (PRWEB) July 30, 2014 ... of Melinda J. Helbock A.P.C. are announcing that they are ... from the negative effects of asbestos exposure. , “Symptoms ... that were exposed to the toxin 30 plus years ago ... Melinda Helbock, Founder of The Law Office of Melinda J. ...
(Date:7/30/2014)... TN (PRWEB) July 30, 2014 Regents ... medical imaging services, has brought health care industry veteran ... on board to help lead the company’s ambitious plans ... , “Regents Health has been moving along at a ... to kick it up a notch,” says Bob Maier, ...
Breaking Medicine News(10 mins):Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 2Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 4Health News:Single Women Motorcycle Riders In Rapid Increase 2Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 2Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 3Health News:The Law Office of Melinda J. Helbock A.P.C. Offers Case Evaluations for Possible Asbestos Claims 2Health News:Sferrella and Demonbreun Join Regents Health Resources 2
... them women, suffer from lupus, a disease where the ... week marks a significant step forward in understanding how ... new studies identifying genes involved in this often debilitating ... of the division of Rheumatology and director of Rheumatology ...
... length, group advises , , SUNDAY, Jan. 20 (HealthDay News) -- ... illness, it can be a challenge to take care of ... serious complications, says the American Diabetes Association. , "People ... weather," Ann Albright, the ADA,s president of health care and ...
... Jan. 18 Following the New Hampshire primary,a headline ... life.", Ironically, Joe Dolphin, who announced his endorsement ... a lung transplant, is also hoping,to receive breath that ... leader has suffered for many years with AAT (Alpha-1 ...
... has been named the national lead center for ... pediatric heart pump called Berlin Heart EXCOR® Pediatric ... MD, chief of pediatric and congenital heart surgery ... Department of Surgery at Baylor College of Medicine, ...
... Pharmacyclics,Inc. (Nasdaq: PCYC ) today announced ... its second quarter 2008 financial results and achievements ... (1:30 p.m. PDT)., To participate in the ... 706-758-3306 for international callers and reference,conference passcode, 31926585. ...
... from,the Academy of Columbus, an Imagine charter school, will ... A Smile! Day state kick-off in,Columbus on Friday, Feb.1., ... in the Atrium at the,Ohio Statehouse with dentists, dental ... of Dentistry, legislators and other,dignitaries participating. At the event, ...
Cached Medicine News:Health News:NEJM editorial on significance and limitations of new lupus gene expression research 2Health News:NEJM editorial on significance and limitations of new lupus gene expression research 3Health News:NEJM editorial on significance and limitations of new lupus gene expression research 4Health News:Illness Presents Diabetics With Special Challenges 2Health News:Long-Time San Diego Community Leader, Transplant Patient, Joe Dolphin, Endorses John Mccain 2Health News:National study will look at German-made heart pump for children needing heart transplants 2Health News:National study will look at German-made heart pump for children needing heart transplants 3Health News:Statehouse Atrium to be Site for Children's Dental Access Event - Ohio Legislators to Mingle With Children and Dentists for This Free Care Event! 2
(Date:7/29/2014)... July 29, 2014 New high priced hepatitis ... D by a projected $2.9 to $5.8 billion next ... firm Milliman released today by the Pharmaceutical Care Management ... could increase by as much as 8.6 percent in ... including Sovaldi and Olysio. The study finds ...
(Date:7/29/2014)... July, 29  2014 ISPE—the International Society for ... John Bournas as President and CEO, succeeding ... leave the Society last fall.  Mr. Bournas takes ... the healthcare association industry as well as significant ... clear vision for the expansion of its global ...
(Date:7/29/2014)... July 29, 2014 /PRNewswire-iReach/ -- MHG Medical Management ... launched its Medical Equipment and X-ray Annual ... are tailored to the cruise industry,s unique requirements.  ... operators to propose that they should develop a ... program is intended to create standardized processes and ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2
... (NYSE: WPI ), a leading specialty global ... and Chief Executive Officer, will provide an overview and ... Bernstein 28th Annual Strategic Decisions Conference on Wednesday, May ... Hotel in New York, New York.  The presentation will ...
...  Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has ... Administration for its abbreviated new drug application (ANDA) for ... have already begun.  (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ... U.S. store brand market is bioequivalent to Novartis, Prevacid® ...
Cached Medicine Technology:Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference 2Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules 2
Molt periosteal elevator #9, 18.5 cm, 7-1/4"....
Periosteal elevator #9, 18 cm, 7"....
Full curve periosteal elevator - cervical - sharp, round tip, length 184 mm (7 1/4")....
... The Frontier Anterior Deformity System ... Kass, Moss Miami, and Isola ... thoracoscopic procedures to deliver unsurpassed versatility, ... the highest level of versatility for ...
Medicine Products: